const datasets = {
    "overview": {
      "name": "Topic Overview",
      "children": [
        {
          "name": "Pharmacology",
          "children": [
            {
              "name": "Pharmacodynamics",
              "children": [
                {
                  "name": "Mechanism of action"
                },
                {
                  "name": "Animal Models of Disorders"
                },
                {
                  "name": "Other"
                }
              ]
            },
            {
              "name": "Pharmacokinetics"
            },
            {
              "name": "Pharmacogenetics"
            },
            {
              "name": "Analytical Methods"
            },
            {
              "name": "Other"
            }
          ]
        },
        {
          "name": "Indications",
          "children": [
            {
              "name": "Disorders",
              "children": [
                {
                  "name": "Depressive Disorders"
                },
                {
                  "name": "Anxiety"
                },
                {
                  "name": "Weight and Eating Disorders"
                },
                {
                  "name": "Substance Abuse/Addictions"
                },
                {
                  "name": "Other"
                }
              ]
            }
          ]
        },
        {
          "name": "Safety",
          "children": [
            {
              "name": "Special Populations",
              "children": [
                {
                  "name": "Pediatrics"
                },
                {
                  "name": "Geriatrics"
                },
                {
                  "name": "Other"
                }
              ]
            },
            {
              "name": "Perinatal Exposure"
            },
            {
              "name": "Suicide"
            },
            {
              "name": "Sexual Dysfunction"
            },
            {
              "name": "Toxicity"
            },
            {
              "name": "Other"
            }
          ]
        },
        {
          "name": "Other",
          "children": [
            {
              "name": "Ecotoxicology"
            },
            {
              "name": "Alternative Treatments"
            },
            {
              "name": "Other"
            }
          ]
        }
      ]
    },
    "pharmacology": {
      "name": "Pharmacology",
      "children": [
        {
          "name": "Pharmacodynamics",
          "children": [
            {
              "name": "Mechanism of action",
              "children": [
                {
                  "name": "Serotonin Receptor Modulation in SSRI Treatment"
                },
                {
                  "name": "Impact of SSRIs on Neurogenesis"
                },
                {
                  "name": "SSRIs Effect on Neural Processing of Emotional Cues"
                },
                {
                  "name": "Paroxetine Binding"
                },
                {
                  "name": "SSRIs Effect on Fear"
                },
                {
                  "name": "Structural Basis of Serotonin Transporter Inhibition by SSRIs"
                },
                {
                  "name": "SSRIs and Inflammation"
                },
                {
                  "name": "SSRIs Effects on Neuroendocrine System"
                },
                {
                  "name": "SSRIs for Substance Abuse (Cocaine)"
                },
                {
                  "name": "SSRIs Effects on Ion Channels"
                },
                {
                  "name": "SSRIs Effects on Antimicrobials and Gut Microbiome"
                },
                {
                  "name": "Astrocyte Receptors as a Target for SSRIs"
                },
                {
                  "name": "Repeated SSRIs Exposures Effects on Dopamine Receptors"
                },
                {
                  "name": "SSRIs in Model Organisms ( C. Elegans and Drosophilia)"
                },
                {
                  "name": "Predicting SSRI Response in Depression via miRNA and BDNF"
                },
                {
                  "name": "SSRIs Effect on Reinforcement Learning in Rodents"
                },
                {
                  "name": "Neurochemical and Electrophysiological Correlates of SSRIs"
                },
                {
                  "name": "SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients"
                },
                {
                  "name": "Paroxetines Therapeutic Potential as G Protein-coupled Receptor Kinase 2 (GRK2) Inhibitor for Cardiovascular Diseases"
                },
                {
                  "name": "Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression"
                },
                {
                  "name": "Tryptophan Depletion in Depression"
                }
              ]
            },
            {
              "name": "Animal Models of Disorders",
              "children": [
                {
                  "name": "The Chronic Unpredictable Mild Stress Model of Depression"
                },
                {
                  "name": "SSRIs in Forced Swimming Test"
                },
                {
                  "name": "Olfactory Bulbectomized (OB) Rat Model of Depression"
                }
              ]
            },
            {
              "name": "Other",
              "children": [
                {
                  "name": "SSRIs Effect on Pulmonary Hypertension"
                },
                {
                  "name": "SRRIs and Ocular Safety"
                }
              ]
            }
          ]
        },
        {
          "name": "Pharmacokinetics",
          "children": [
            {
              "name": "SSRIs and the Cytochrome P450 System"
            },
            {
              "name": "(Sertraline) Drug Delivery"
            }
          ]
        },
        {
          "name": "Pharmacogenetics",
          "children": [
            {
              "name": "Serotonin Transporter Gene and Antidepressant Response"
            },
            {
              "name": "Genotype Mediated Response to SSRIs"
            }
          ]
        },
        {
          "name": "Analytical Methods",
          "children": [
            {
              "name": "Quantification of SSRIs in Biological Samples"
            },
            {
              "name": "Novel Compounds Synthesis and Antidepressant Potential"
            }
          ]
        },
        {
          "name": "Other",
          "children": [
            {
              "name": "Risks of Prenatal Exposure"
            },
            {
              "name": "SSRI Synthesis"
            },
            {
              "name": "Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity"
            },
            {
              "name": "SSRIs Effect on Male Fertility"
            }
          ]
        }
      ]
    },
    "indications": {
      "name": "Indications",
      "children": [
        {
          "name": "Disorders",
          "children": [
            {
              "name": "Depressive Disorders",
              "children": [
                {
                  "name": "The Chronic Unpredictable Mild Stress Model of Depression"
                },
                {
                  "name": "Fluvoxamine for Depression"
                },
                {
                  "name": "Pediatric Depression"
                },
                {
                  "name": "SSRIs in Forced Swimming Test"
                },
                {
                  "name": "Sequenced Depression Treatment"
                },
                {
                  "name": "Serotonin Transporter Gene and Antidepressant Response"
                },
                {
                  "name": "Post-Stroke SSRI Use"
                },
                {
                  "name": "SSRIs for Bipolar Depression"
                },
                {
                  "name": "Escitalopram for Depression"
                },
                {
                  "name": "Pharmacoeconomics of SSRIs for Depression"
                },
                {
                  "name": " Depression in Patients with Cardiovascular Disease"
                },
                {
                  "name": "Pharmacological Treatment Strategies of Depression"
                },
                {
                  "name": "SSRIs for Depression in Diabetes Patients"
                },
                {
                  "name": "SSRIs for Depression with Cognitive Impairment"
                },
                {
                  "name": "SSRIs for Depression in in Epileptic Patients"
                },
                {
                  "name": "SSRIs for Depression in Parkinsons Patients"
                },
                {
                  "name": "Geriatric Depression"
                },
                {
                  "name": "Agomelatin for Depression"
                },
                {
                  "name": "SSRIs and Augmentation for Treatment Resistant Depression"
                },
                {
                  "name": "Depression Treatment in Hepatitis Patients"
                },
                {
                  "name": "SSRIs for Depression after Traumatic Brain Injury"
                },
                {
                  "name": "Sex differences in SSRI Response"
                },
                {
                  "name": "SRRIs and Ocular Safety"
                },
                {
                  "name": "Transcranial Direct Current Stimulation (tDCS) for Depression"
                },
                {
                  "name": "SSRIs for Depression in Cancer"
                },
                {
                  "name": "SSRIs for Dysthymia"
                },
                {
                  "name": "SSRIs for Postpartum Depression"
                },
                {
                  "name": "St. John's Wort for Depression"
                },
                {
                  "name": "SSRIs for Depression in Kidney Disease Patients"
                },
                {
                  "name": "SSRIs for Depression in Kidney Disease Patients"
                },
                {
                  "name": "Predicting SSRI Response in Depression via miRNA and BDNF"
                },
                {
                  "name": "Vilazodone for Depression"
                },
                {
                  "name": "SSRIs for the Mangement of Multiple Sclerosis"
                },
                {
                  "name": "Folate for Depression"
                },
                {
                  "name": "SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients"
                },
                {
                  "name": "SSRIs Effect on Brain-derived Neurotrophic Factor (BDNF) Levels in Depressive Patients"
                },
                {
                  "name": "SSRIs for Depression in HIV-positive Patients"
                },
                {
                  "name": "Loudness Dependence of Auditory Evoked Potentials (LDAEP) as Biomarker for Depression"
                },
                {
                  "name": "Olfactory Bulbectomized (OB) Rat Model of Depression"
                },
                {
                  "name": "Tryptophan Depletion in Depression"
                }
              ]
            },
            {
              "name": "Anxiety",
              "children": [
                {
                  "name": "SSRIs Effect on Fear"
                },
                {
                  "name": "SSRIs for Panic Disorder"
                },
                {
                  "name": "SSRIs for Generalized Anxiety Disorder (GAD)"
                },
                {
                  "name": "SSRIs for Social Anxiety Disorder"
                },
                {
                  "name": "SSRIs for Pediatric Anxiety"
                }
              ]
            },
            {
              "name": "Weight and Eating Disorders",
              "children": [
                {
                  "name": "SSRIs for Weight Management"
                },
                {
                  "name": "SSRIs for Eating Disorders"
                }
              ]
            },
            {
              "name": "Substance Abuse/Addictions",
              "children": [
                {
                  "name": "SSRIs for Alcohol Dependence"
                },
                {
                  "name": "SSRIs for Substance Abuse (Cocaine)"
                },
                {
                  "name": "SSRIs for Behavioral Addictions"
                },
                {
                  "name": "SSRIs for Smoking Cessation"
                }
              ]
            },
            {
              "name": "Other",
              "children": [
                {
                  "name": "SSRIs for Obsessive-Compulsive Disorder (OCD)"
                },
                {
                  "name": "SSRIs for PTSD"
                },
                {
                  "name": "SSRIs in Dementias"
                },
                {
                  "name": "SSRIs for Pain"
                },
                {
                  "name": "SSRIs for (Psycho)dermatological Diseases"
                },
                {
                  "name": "SSRIs Effect on Sleep"
                },
                {
                  "name": "Fluvoxamine for Covid 19"
                },
                {
                  "name": "Premature Ejaculation"
                },
                {
                  "name": "SSRIs for Premenstrual Dysphoric Disorder (PMDD)"
                },
                {
                  "name": "SSRIs for Irritable Bowel Syndrome"
                },
                {
                  "name": "Menopausal Vasomotor Symptoms (Hot flashes)"
                },
                {
                  "name": "SSRIs for Borderline Personality Disorder"
                },
                {
                  "name": "SSRIs for Autism Spectrum Disorders"
                },
                {
                  "name": "SSRIs (Fluvoxamine) for Schizophrenia"
                },
                {
                  "name": "SSRIs Effect on Pulmonary Hypertension"
                },
                {
                  "name": "SSRIs for Body Dysmorphic Disorder (BDD)"
                },
                {
                  "name": "SSRIs for Fibromyalgia"
                },
                {
                  "name": "Risk for Orofacial Pain Disorders"
                },
                {
                  "name": "SSRIs for Enuresis"
                },
                {
                  "name": "SSRIs for Migraine"
                },
                {
                  "name": "SSRIs for Trichotillomania"
                },
                {
                  "name": "SSRIs for Congenital Myasthenic Syndrome (SCCMS)"
                },
                {
                  "name": "SSRIs in the Treatment of Huntington Disease"
                },
                {
                  "name": "SSRIs for Tinnitus "
                },
                {
                  "name": "SSRIs for Syncope"
                }
              ]
            }
          ]
        }
      ]
    },
    "safety": {
      "name": "Safety",
      "children": [
        {
          "name": "Special Populations",
          "children": [
            {
              "name": "Pediatrics",
              "children": [
                {
                  "name": "Pediatric Depression"
                },
                {
                  "name": "SSRIs for Pediatric Anxiety"
                }
              ]
            },
            {
              "name": "Geriatrics",
              "children": [
                {
                  "name": "SSRIs in Dementias"
                },
                {
                  "name": "Fracture Risk"
                },
                {
                  "name": "SSRIs for Depression with Cognitive Impairment"
                },
                {
                  "name": "SSRIs for Depression in Parkinsons Patients"
                },
                {
                  "name": "Harmful Drug Interactions"
                },
                {
                  "name": "Hyponatremia Risk"
                },
                {
                  "name": "Geriatric Depression"
                }
              ]
            },
            {
              "name": "Other",
              "children": [
                {
                  "name": "Post-Stroke SSRI Use"
                },
                {
                  "name": " Depression in Patients with Cardiovascular Disease"
                },
                {
                  "name": "SSRIs for Depression in Diabetes Patients"
                },
                {
                  "name": "SSRIs for Depression in in Epileptic Patients"
                },
                {
                  "name": "Depression Treatment in Hepatitis Patients"
                },
                {
                  "name": "SSRIs for Depression after Traumatic Brain Injury"
                },
                {
                  "name": "SSRIs for Depression in Cancer"
                },
                {
                  "name": "SSRIs for Depression in Kidney Disease Patients"
                },
                {
                  "name": "SSRIs for the Mangement of Multiple Sclerosis"
                },
                {
                  "name": "SSRIs for Depression in Chronic Obstructive Pulmonary Disease (COPD) Patients"
                },
                {
                  "name": "SSRIs for Depression in HIV-positive Patients"
                }
              ]
            }
          ]
        },
        {
          "name": "Perinatal Exposure",
          "children": [
            {
              "name": "Risks of Prenatal Exposure"
            },
            {
              "name": "Risk of Perinatal Exposure (Rodents)"
            },
            {
              "name": "SSRIs for Postpartum Depression"
            }
          ]
        },
        {
          "name": "Suicide",
          "children": [
            {
              "name": "The Chronic Unpredictable Mild Stress Model of Depression"
            },
            {
              "name": "Suicice Risk"
            }
          ]
        },
        {
          "name": "Sexual Dysfunction",
          "children": [
            {
              "name": "Sexual Dysfunction"
            },
            {
              "name": "SSRIs Effect on Male Fertility"
            }
          ]
        },
        {
          "name": "Toxicity",
          "children": [
            {
              "name": "Serotonin Syndrome"
            },
            {
              "name": "Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity"
            },
            {
              "name": "Forensic Drug Concentration"
            },
            {
              "name": "Hepatotoxic Risk"
            }
          ]
        },
        {
          "name": "Other",
          "children": [
            {
              "name": "Bleeding Risk"
            },
            {
              "name": "QTC Prolongation"
            },
            {
              "name": "Oncopreventive and Oncolytic Properties of SSRIs"
            },
            {
              "name": "Extrapyramidal Reactions Risk"
            },
            {
              "name": "SSRIs for Social Anxiety Disorder"
            },
            {
              "name": "SSRI Safety Reviews"
            },
            {
              "name": "Withdrawal Symptoms"
            },
            {
              "name": "Repeated SSRIs Exposures Effects on Dopamine Receptors"
            },
            {
              "name": "Hyperprolactinemia-related Symptoms"
            },
            {
              "name": "SRRIs and Ocular Safety"
            },
            {
              "name": "Risk for Orofacial Pain Disorders"
            },
            {
              "name": "Risk of Hallucinations"
            }
          ]
        }
      ]
    },
    "other": {
      "name": "Other",
      "children": [
        {
          "name": "Ecotoxicology",
          "children": [
            {
              "name": "Aquatic Ecotoxicology"
            },
            {
              "name": "Environmental Degradation of Antidepressants"
            }
          ]
        },
        {
          "name": "Alternative Treatments",
          "children": [
            {
              "name": "Antidepressant-like Effects of Herbal Extracts in Animal Models"
            },
            {
              "name": "St. John's Wort for Depression"
            }
          ]
        },
        {
          "name": "Other",
          "children": [
            {
              "name": "SSRI Utilization Patterns"
            },
            {
              "name": "Pharmacoeconomics of SSRIs for Depression"
            },
            {
              "name": "Menopausal Vasomotor Symptoms (Hot flashes)"
            },
            {
              "name": "Canine Behavioral Disorders"
            },
            {
              "name": "Generic SSRIs"
            },
            {
              "name": "Critical Psychiatry"
            }
          ]
        }
      ]
    }
  };
  